课题基金 / 基金详情

项目摘要

项目成果

Gerald J Gleich的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Eosinophils are immune cells that develop in the bone marrow in response to interleukins-3, -5 (IL-3, IL-5) and granulocyte macrophage colony stimulating factor (GM-CSF). Mature eosinophils migrate to the gut and are involved in parasitic immunity, especially to helminthes. Eosinophils are also associated with many allergic diseases including asthma, atopic dermatitis, drug reactions and chronic urticaria. Eosinophil-associated gastrointestinal diseases include eosinophilic esophagitis, eosinophilic gastroenteritis and collagenous colitis. The hypereosinophilic syndrome includes patients with marked increases in eosinophils. The eosinophil is also involved in diseases caused by adulterated food products such as eosinophilia myalgia syndrome and toxic oil syndrome. Glucocorticoids have been used as a treatment for many of these diseases; however, long-term steroid usage causes significant side effects. Values for such assays can only be placed in meaningful context with comparison against normal patient values. Because of inter-laboratory variations in equipment, technique, and reagents, literature values will usually not suffice. It is necessary for each laboratory to establish normal values for the assays. Further, normal patient samples should be frequently run alongside study participant samples, in order to confirm that the equipment remains calibrated and technique unchanged. The objective of this project is to verify that equipment is consistently calibrated and working, as well as to obtain a range of normal values against which to compare patient samples for a number of present and future studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a Treatment for Eosinophil-Mediated Allergic Inflammatory Diseases Utilizing a Neutralizing Agent Targeting Eosinophil Granule Major Basic Protein
  • 批准号:
    10401936
  • 项目类别:
  • 资助金额:
    $29.07万
  • 财政年份:
    2021
  • 负责人:
    Gerald J Gleich
  • 依托单位:
Development of a Treatment for Eosinophil-Mediated Allergic Inflammatory Diseases Utilizing a Neutralizing Agent Targeting Eosinophil Granule Major Basic Protein
  • 批准号:
    10257909
  • 项目类别:
  • 资助金额:
    $29.98万
  • 财政年份:
    2021
  • 负责人:
    Gerald J Gleich
  • 依托单位:
Novel, Non-InvasiveImaging of Eosinophil-Related Inflammation Throughout the Esophagus in Patients withEosinophilic Esophagitis
  • 批准号:
    10017684
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2020
  • 负责人:
    Gerald J Gleich
  • 依托单位:
TMEM103 in Eosinophil Development
  • 批准号:
    7660267
  • 项目类别:
  • 资助金额:
    $18.81万
  • 财政年份:
    2009
  • 负责人:
    Gerald J Gleich
  • 依托单位:
海外基金